Fig. 3From: Transcription factor LHX9 (LIM Homeobox 9) enhances pyruvate kinase PKM2 activity to induce glycolytic metabolic reprogramming in cancer stem cells, promoting gastric cancer progressionSurvival curve and ROC curve to evaluate the predictive value of LHX9 expression on the prognosis of GC patients. A: box line plot of the difference in LHX9 expression in GC tissues and normal gastric mucosal tissues; B: Kaplan–Meier survival analysis curves of GC patients in the high LHX9 expression group and low LHX9 expression group; C-D: time-dependent ROC curves and and PR curves to evaluate the diagnostic value of LHX9 on the prognosis of GC patients; E: single-factor independent prognostic analysis forest plot; F: multi-factor independent prognostic analysis forest plots; G: survival curves to evaluate the predictive efficacy of LHX9 on PFS in GC patientsBack to article page